Sfoglia per Autore
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.
2003-01-01 Milani, D; Zauli, G; Rimondi, Erika; Celeghini, Claudio; Marmiroli, S; Narducci, P; Capitani, S; Secchiero, P.
TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points:induction of apoptosis and PGE2 release.
2003-01-01 Zauli, G.; Milani, D.; Rimondi, Erika; Baldini, G.; Nicolin, Vanessa; Grill, Vittorio; Secchiero, P.
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells.
2004-01-01 Secchiero, P; Zerbinati, C; Rimondi, Erika; Corallini, Federica; Milani, D; Grill, Vittorio; Forti, G; Capitani, S; Zauli, G.
TNF-related apoptosis inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
2004-01-01 Zauli, G; Rimondi, Erika; Nicolin, Vanessa; Melloni, E; Celeghini, Claudio; Secchiero, P.
MDM2 antagonist nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts via a p53-dependent pathway.
2007-01-01 Zauli, G; Rimondi, Erika; Corallini, Federica; Fadda, R; Capitani, S; Secchiero, P.
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors.
2007-01-01 Zauli, G; Rimondi, Erika; Stea, S; Baruffaldi, F; Stebel, M; Zerbinati, C; Corallini, Federica; Secchiero, P.
Receptor activator of nuclear factor kappa B ligand(RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts.
2007-01-01 Rimondi, Erika; Zweyer, Marina; Ricci, E; Fadda, R; Secchiero, P.
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells.
2008-01-01 Barbarotto, E; Corallini, F; Rimondi, Erika; Fadda, R; Mischiati, C; Grill, Vittorio; Vaccarezza, M; Celeghini, Claudio
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells
2008-01-01 Secchiero, P; Corallini, F; Rimondi, Erika; Chiaruttini, C; DI IASIO, Mg; Rustighi, Alessandra; DEL SAL, Giannino; Zauli, G.
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members.
2009-01-01 Gonelli, A.; Milani, D.; Rimondi, Erika; Voltan, R.; Grill, Vittorio; Celeghini, Claudio
Activation of PKC-e counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members.
2009-01-01 Gonelli, A; Milani, D; Rimondi, Erika; Voltan, R; Grill, Vittorio; Celeghini, C.
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL).
2010-01-01 Zauli, G.; Rimondi, Erika; Celeghini, Claudio; Milani, D.; Secchiero, P.
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside.
2011-01-01 Bosco, R.; Melloni, E.; Celeghini, Claudio; Rimondi, Erika; Vaccarezza, M.; Zauli, G.
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines.
2011-01-01 Celeghini, Claudio; Voltan, R.; Rimondi, Erika; Gattei, V.; Zauli, G.
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells.
2011-01-01 Corallini, F.; Celeghini, Claudio; Rimondi, Erika; di Iasio, M. G.; Gonelli, A.; Secchiero, P.; Zauli, G.
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1.
2012-01-01 Rimondi, Erika; Secchiero, P; Melloni, E; Grill, Vittorio; Zauli, G.
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells.
2012-01-01 Rimondi, Erika; di Iasio, M. G.; Gonelli, A.; Celeghini, Claudio; Secchiero, P.; Zauli, G.
Human colostrum and breast milk contain high levels of TNF-related apoptosis-inducing ligand (TRAIL).
2013-01-01 R., Davanzo; G., Zauli; L., Monasta; L., Vecchi Brumatti; M. V., Abate; G., Ventura; Rimondi, Erika; P., Secchiero; S., Demarini
Inhibitory effect of natural anti-inflammatory compounds on cytokines released by chronic venous disease patient-derived endothelial cells.
2013-01-01 V., Tisato; G., Zauli; Rimondi, Erika; S., Gianesini; L., Brunelli; E., Menegatti; P., Zamboni; P., Secchiero
GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients.
2013-01-01 V., Tisato; P., Secchiero; Rimondi, Erika; S., Gianesini; E., Menegatti; F., Casciano; P., Zamboni; G., Zauli
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile